Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 14 of 14

List	Outcome	Time frame	Description
Primary	Feasibility of trial conduct	Up to 30 days	Feasibility will be assessed by recruitment rate, consent rate, intervention fidelity, and completeness of follow-up and outcome ascertainment at 30 days.
Secondary	Recruitment Rate	Up to 24 months (recruitment period)	Number of participants enrolled per site per month.
Secondary	Consent Rate	Up to 30 days	Proportion of eligible patients who provide consent.
Secondary	Intervention Fidelity	During index hospitalization	Adherence to assigned strategy and separation between randomized groups.
Secondary	Completeness of Follow-up	Up to 30 days	Proportion of participants with complete follow-up and outcome ascertainment.
Other	All-Cause Mortality	Up to 30 days	All-cause death following randomization.
Other	All-Cause Hospital Readmission	Up to 30 days	Hospital readmission for any cause following discharge from the index hospitalization.
Other	Heart Failure Readmission	Up to 30 days	Hospital readmission due to heart failure following discharge from the index hospitalization.
Other	Clinically Significant Arrhythmia	Up to 30 days	Incident new or worsened clinically significant supraventricular or ventricular arrhythmia during the index hospitalization.
Other	Symptomatic Hypotension	During index hospitalization	Occurrence of symptomatic hypotension during the index hospitalization.
Other	Serious Adverse Events (SAEs)	Up to 30 days	Serious adverse events occurring during the index hospitalization.
Other	Intensive Care Unit (ICU) Admission	Up to 30 days	Admission to the intensive care unit during the index hospitalization.
Other	Length of Hospital Stay	Up to 30 days	Duration of the index hospitalization in days.
Other	Change in Kansas City Cardiomyopathy Questionnaire Total Symptom Score (KCCQ-TSS)	Up to 30 days	Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) Total Symptom Score from baseline to Day 5 comparing treatment groups. The Kansas City Cardiomyopathy Questionnaire Total Symptom Score (KCCQ-TSS) ranges from 0 to 100, where higher scores indicate fewer heart failure symptoms and better health status, and lower scores indicate more severe symptoms and worse health status.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07906353/registered

API reference For AI assistants